韩国做爰无遮A片床戏,第一财经电视直播,女人18毛片水真多,老头猛吸女大学奶头A片,借种灭门案完整观看国语

Advances In Clinical And Experimental Medicine
收藏雜(za)志(zhi)
  • 數據庫收(shou)錄SCIE
  • 創刊年(nian)份1998年
  • 年(nian)發文量(liang)187
  • H-index21

Advances In Clinical And Experimental Medicine

期刊中文(wen)名:臨床和實驗醫學(xue)進展ISSN:1899-5276E-ISSN:2451-2680

該雜(za)志國(guo)際簡(jian)稱:ADV CLIN EXP MED,是由出版(ban)商Wroclaw Medical University出版(ban)的(de)(de)一本致(zhi)力(li)(li)于發(fa)(fa)布醫學(xue)(xue)(xue)研究(jiu)新成果(guo)的(de)(de)的(de)(de)專業(ye)學(xue)(xue)(xue)術(shu)期刊(kan)。該雜(za)志以MEDICINE, RESEARCH & EXPERIMENTAL研究(jiu)為重(zhong)點,主(zhu)要發(fa)(fa)表刊(kan)登有(you)創(chuang)見的(de)(de)學(xue)(xue)(xue)術(shu)論文(wen)文(wen)章、行業(ye)最新科研成果(guo),扼要報(bao)道階段性研究(jiu)成果(guo)和重(zhong)要研究(jiu)工作(zuo)的(de)(de)最新進展(zhan),選載對學(xue)(xue)(xue)科發(fa)(fa)展(zhan)起指導作(zuo)用的(de)(de)綜述與專論,促進學(xue)(xue)(xue)術(shu)發(fa)(fa)展(zhan),為廣大讀者服務。該刊(kan)是一本國(guo)際優秀雜(za)志,在國(guo)際上有(you)很高(gao)的(de)(de)學(xue)(xue)(xue)術(shu)影響力(li)(li)。

基本信息:
期刊簡稱(cheng):ADV CLIN EXP MED
是(shi)否OA:開放
是否預警:
Gold OA文章(zhang)占比:94.51%
出版信息:
出(chu)版地區:POLAND
出版周期:Monthly
出版語言(yan):English
出版商:Wroclaw Medical University
評價信息:
中(zhong)科院分(fen)區(qu):4區
JCR分(fen)區:Q3
影(ying)響因子:2.1
CiteScore:3.7
雜志介(jie)紹(shao) 中科院JCR分區 JCR分區 CiteScore 投稿(gao)經驗

雜志介紹

Advances In Clinical And Experimental Medicine雜志介紹

《Advances In Clinical And Experimental Medicine》是一本(ben)(ben)(ben)以(yi)English為(wei)(wei)主的(de)開放(fang)獲取國(guo)際優(you)秀期刊(kan)(kan),中文名稱臨床和實驗(yan)醫學(xue)進(jin)展,本(ben)(ben)(ben)刊(kan)(kan)主要出(chu)版、報道(dao)醫學(xue)-MEDICINE, RESEARCH & EXPERIMENTAL領域(yu)(yu)的(de)研(yan)究動態以(yi)及在該領域(yu)(yu)取得的(de)各(ge)方面的(de)經驗(yan)和科研(yan)成果,介紹(shao)該領域(yu)(yu)有關本(ben)(ben)(ben)專(zhuan)業(ye)的(de)最新進(jin)展,探討行業(ye)發展的(de)思路和方法,以(yi)促進(jin)學(xue)術信息交流,提高(gao)行業(ye)發展。該刊(kan)(kan)已(yi)被國(guo)際權威數(shu)據庫SCIE收錄,為(wei)(wei)該領域(yu)(yu)相關學(xue)科的(de)發展起到了(le)良(liang)好的(de)推(tui)動作用,也得到了(le)本(ben)(ben)(ben)專(zhuan)業(ye)人(ren)員的(de)廣泛認(ren)可。該刊(kan)(kan)最新影響因子為(wei)(wei)2.1,最新CiteScore 指(zhi)數(shu)為(wei)(wei)3.7。

本(ben)刊近(jin)期中國(guo)學者發表的論文主(zhu)要有:

  • Meta-analysis of outcomes related to the quality of life after orthodontic-surgical treatment

    Author: Li, Xiangyu; Zheng, Weiying; Zhang, Xi; Zhang, Yumen

  • Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways

    Author: Wang, Manfeng; Liu, Meiling; Xu, Wanzhen; Teng, Zongyan; Wu, Xiaowei; Gan, Lu; Zhang, Yina

  • A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-beta 1/Smads pathway

    Author: Zhang, Ronghua; Wang, Meimei; Lu, Hongjian; Wang, Jingyao; Han, Xiangyang; Liu, Zhiyong; Li, Lin; Li, Mingming; Tian, Xiaoli; Chen, Shuang; Zhang, Guangling; Xiong, Yanan; Li, Jingwu

  • The relationship between non-alcoholic fatty liver disease and incidence of chronic kidney disease for diabetic and non-diabetic subjects: A meta-analysis

    Author: Chen, Yueqiao; Bai, Wenjie; Mao, Dewen; Long, Fuli; Wang, Na; Wang, Kejing; Shi, Qinglan

英文介紹

Advances In Clinical And Experimental Medicine雜志英文介紹

Advances in Clinical and Experimental Medicine has been published by the Wroclaw Medical University since 1992. Establishing the medical journal was the idea of Prof. Bogumi? Halawa, Chair of the Department of Cardiology, and was fully supported by the Rector of Wroclaw Medical University, Prof. Zbigniew Knapik. Prof. Halawa was also the first editor-in-chief, between 1992-1997. The journal, then entitled "Post?py Medycyny Klinicznej i Do?wiadczalnej", appeared quarterly.

Prof. Leszek Paradowski was editor-in-chief from 1997-1999. In 1998 he initiated alterations in the profile and cover design of the journal which were accepted by the Editorial Board. The title was changed to Advances in Clinical and Experimental Medicine. Articles in English were welcomed. A number of outstanding representatives of medical science from Poland and abroad were invited to participate in the newly established International Editorial Staff.

Prof. Antonina Har?ozińska-Szmyrka was editor-in-chief in years 2000-2005, in years 2006-2007 once again prof. Leszek Paradowski and prof. Maria Podolak-Dawidziak was editor-in-chief in years 2008-2016. Since 2017 the editor-in chief is prof. Maciej Bag?aj.

Since July 2005, original papers have been published only in English. Case reports are no longer accepted. The manuscripts are reviewed by two independent reviewers and a statistical reviewer, and English texts are proofread by a native speaker.

The journal has been indexed in several databases: Scopus, Ulrich’sTM International Periodicals Directory, Index Copernicus and since 2007 in Thomson Reuters databases: Science Citation Index Expanded i Journal Citation Reports/Science Edition.

In 2010 the journal obtained Impact Factor which is now 1.179 pts. Articles published in the journal are worth 15 points among Polish journals according to the Polish Committee for Scientific Research and 169.43 points according to the Index Copernicus.

Since November 7, 2012, Advances in Clinical and Experimental Medicine has been indexed and included in National Library of Medicine’s MEDLINE database. English abstracts printed in the journal are included and searchable using PubMed //www.ncbi.nlm.nih.gov/pubmed.

中科院SCI分區

Advances In Clinical And Experimental Medicine雜志中科院分區信息

2023年(nian)12月升級版
綜述:
TOP期刊:
大類:醫學 4區
小類:

MEDICINE, RESEARCH & EXPERIMENTAL
醫學:研究與實驗 4區

2022年12月升級版
綜述:
TOP期刊:
大類:醫學 4區
小類:

MEDICINE, RESEARCH & EXPERIMENTAL
醫學:研究與實驗 4區

2021年12月舊的升級(ji)版(ban)
綜述:
TOP期刊:
大類:醫學 4區
小類:

MEDICINE, RESEARCH & EXPERIMENTAL
醫學:研究與實驗 4區

2021年12月基礎版
綜述:
TOP期刊:
大類:醫學 4區
小類:

MEDICINE, RESEARCH & EXPERIMENTAL
醫學:研究與實驗 4區

2021年(nian)12月升級版(ban)
綜述:否(fou)
TOP期刊:
大類:醫學 4區
小類:

MEDICINE, RESEARCH & EXPERIMENTAL
醫學:研究與實驗 4區

2020年(nian)12月舊(jiu)的升(sheng)級版
綜述:
TOP期刊:
大類:醫學 4區
小類:

MEDICINE, RESEARCH & EXPERIMENTAL
醫學:研究與實驗 4區

中科院SCI分區:是中國科(ke)(ke)(ke)學院文獻情報(bao)中心(xin)科(ke)(ke)(ke)學計量(liang)中心(xin)的(de)科(ke)(ke)(ke)學研究成果(guo)。期刊分區(qu)(qu)(qu)表(biao)自(zi)2004年(nian)開始發(fa)(fa)布(bu),延續至今;2019年(nian)推出升(sheng)級版,實(shi)現基礎版、升(sheng)級版并(bing)存過渡,2022年(nian)只發(fa)(fa)布(bu)升(sheng)級版,期刊分區(qu)(qu)(qu)表(biao)數據每年(nian)底發(fa)(fa)布(bu)。 中科(ke)(ke)(ke)院分區(qu)(qu)(qu)為4個區(qu)(qu)(qu)。中科(ke)(ke)(ke)院分區(qu)(qu)(qu)采用刊物前(qian)3年(nian)影響因子(zi)平均(jun)值(zhi)進(jin)行分區(qu)(qu)(qu),即(ji)前(qian)5%為該類1區(qu)(qu)(qu),6%~20%為2區(qu)(qu)(qu)、21%~50%為3區(qu)(qu)(qu),其(qi)余的(de)為4區(qu)(qu)(qu)。1區(qu)(qu)(qu)和(he)2區(qu)(qu)(qu)雜(za)志很少(shao),雜(za)志質(zhi)量(liang)相對也高,基本(ben)都(dou)是本(ben)領域的(de)頂(ding)級期刊。

JCR分區(2023-2024年最新版)

Advances In Clinical And Experimental Medicine雜志 JCR分區信息

按JIF指(zhi)標學科分區
學科:MEDICINE, RESEARCH & EXPERIMENTAL
收錄子集:SCIE
分區:Q3
排名:118 / 189
百分位:

37.8%

按(an)JCI指標(biao)學科(ke)分區
學科:MEDICINE, RESEARCH & EXPERIMENTAL
收錄子集:SCIE
分區:Q4
排名:142 / 189
百分位:

25.13%

JCR分區:JCR分(fen)區來自(zi)科(ke)(ke)(ke)睿唯(wei)安(an)公司,JCR是一(yi)個獨特的(de)多學(xue)科(ke)(ke)(ke)期刊評價工具,為(wei)唯(wei)一(yi)提(ti)供基(ji)于引(yin)文數據的(de)統(tong)計信息的(de)期刊評價資(zi)源(yuan)。每年(nian)發布的(de)JCR分(fen)區,設置(zhi)了254個具體學(xue)科(ke)(ke)(ke)。JCR分(fen)區根據每個學(xue)科(ke)(ke)(ke)分(fen)類按(an)照期刊當年(nian)的(de)影(ying)響因子高(gao)低將期刊平均分(fen)為(wei)4個區,分(fen)別為(wei)Q1、Q2、Q3和Q4,各占(zhan)25%。JCR分(fen)區中期刊的(de)數量是均勻分(fen)為(wei)四個部(bu)分(fen)的(de)。

CiteScore 評價數據(2024年最新版)

Advances In Clinical And Experimental Medicine雜志CiteScore 評價數據

  • CiteScore 值:3.7
  • SJR:0.535
  • SNIP:0.61
學科類別 分區 排名 百分位
大類:Medicine 小類:Reviews and References (medical) Q1 1 / 5

90%

大類:Medicine 小類:Medicine (miscellaneous) Q2 149 / 398

62%

大類:Medicine 小類:General Biochemistry, Genetics and Molecular Biology Q2 104 / 221

53%

大類:Medicine 小類:Internal Medicine Q2 80 / 167

52%

大類:Medicine 小類:Pharmacology (medical) Q2 135 / 272

50%

大類:Medicine 小類:Genetics (clinical) Q3 61 / 99

38%

歷年影響因子和期刊自引率

投稿經驗

Advances In Clinical And Experimental Medicine雜志投稿經驗

該雜(za)志(zhi)(zhi)是一(yi)本國際優(you)秀雜(za)志(zhi)(zhi),在國際上有較(jiao)高(gao)的(de)(de)學術影(ying)響力(li),行業(ye)關注度很(hen)高(gao),已(yi)被國際權威數據庫(ku)SCIE收錄,該雜(za)志(zhi)(zhi)在MEDICINE, RESEARCH & EXPERIMENTAL綜合專業(ye)領域專業(ye)度認可很(hen)高(gao),對稿(gao)(gao)件(jian)內(nei)容的(de)(de)創新性(xing)和(he)學術性(xing)要求(qiu)很(hen)高(gao),作為一(yi)本國際優(you)秀雜(za)志(zhi)(zhi),一(yi)般投(tou)稿(gao)(gao)過審(shen)時間都較(jiao)長,投(tou)稿(gao)(gao)過審(shen)時間平均 較(jiao)慢,6-12周 ,如果想投(tou)稿(gao)(gao)該刊要做好時間安排。版面費不祥。該雜(za)志(zhi)(zhi)近兩年(nian)未被列入預警名單(dan),建議(yi)您投(tou)稿(gao)(gao)。如您想了(le)解更多投(tou)稿(gao)(gao)政策及投(tou)稿(gao)(gao)方(fang)案,請(qing)咨詢客服。

免責聲明

若(ruo)用戶需要出(chu)(chu)版服務,請聯系出(chu)(chu)版商:UL K MARCINKOWSKIEGO 2-6, WROCLAW, Poland, 50-368。